Catheter Precision (VTAK) Enterprise Value (2017 - 2025)
Catheter Precision (VTAK) has disclosed Enterprise Value for 9 consecutive years, with -$1.4 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value fell 13.01% to -$1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.4 million, a 13.01% decrease, with the full-year FY2024 number at -$2.9 million, up 19.41% from a year prior.
- Enterprise Value was -$1.4 million for Q3 2025 at Catheter Precision, down from -$1.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$16000.0 in Q2 2024 to a low of -$20.6 million in Q3 2021.
- A 5-year average of -$8.7 million and a median of -$6.5 million in 2023 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: surged 99.78% in 2024, then plummeted 6637.5% in 2025.
- Catheter Precision's Enterprise Value stood at -$15.0 million in 2021, then decreased by 5.41% to -$15.9 million in 2022, then skyrocketed by 77.52% to -$3.6 million in 2023, then rose by 19.41% to -$2.9 million in 2024, then surged by 50.12% to -$1.4 million in 2025.
- Per Business Quant, the three most recent readings for VTAK's Enterprise Value are -$1.4 million (Q3 2025), -$1.1 million (Q2 2025), and -$500000.0 (Q1 2025).